News / Quality of Life Group
PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI
PRESS RELEASE: EORTC 1945 OligoRARE trial in oligometastatic rare cancers receives support by Anticancer Fund & Rising Tide Foundation
Professor John Gordon McVie BSc (Hons), MBChB, M.D., FRCP, FRCPE, FRCPSGlas, FMedSci, DSc (1945-2021)
Lung Cancer Group / News
PRESS RELEASE: First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study
Webinar: How can current EU policy initiatives pave the way towards treatment optimisation as part of health systems?
EORTC lobbies for reducing the economic burden of cancer by optimising treatment for cancer patients